Previous close | 162.60 |
Open | 161.60 |
Bid | 153.30 x 0 |
Ask | 169.40 x 0 |
Day's range | 160.60 - 162.50 |
52-week range | 151.00 - 238.80 |
Volume | |
Avg. volume | 5,460 |
Market cap | 10.919B |
Beta (5Y monthly) | 0.92 |
PE ratio (TTM) | 44.57 |
EPS (TTM) | 3.62 |
Earnings date | N/A |
Forward dividend & yield | 1.55 (0.96%) |
Ex-dividend date | 29 Apr 2022 |
1y target est | N/A |
Biotage has two financial goals in its business, an organic sales growth goal of 8 percent and a profitability goal of 15 percent (EBIT).
We help shape the sustainable science of tomorrow and our future society for the benefit of humankind – HumanKind Unlimited. With this principle Biotage has set out a commitment to unleashing the potential of humanity by working tirelessly to improve the health and wellbeing of both our customers through greener and more efficient solutions, and our own employees through smarter working practices. As part of HumanKind Unlimited comes a commitment to sustainability at every level within Biotage a
Because of a typo, the board proposal for 2021 dividend is stated as 1 krona and 50 öre in this morning's Swedish public announcement, correct number is 1 krona and 55 öre in accordance with the full year end report 2021.